These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23132694)

  • 21. ICA-based denoising strategies in breath-hold induced cerebrovascular reactivity mapping with multi echo BOLD fMRI.
    Moia S; Termenon M; Uruñuela E; Chen G; Stickland RC; Bright MG; Caballero-Gaudes C
    Neuroimage; 2021 Jun; 233():117914. PubMed ID: 33684602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between hypercarbic reactivity, cerebral blood flow, and arterial circulation times in patients with moyamoya disease.
    Donahue MJ; Ayad M; Moore R; van Osch M; Singer R; Clemmons P; Strother M
    J Magn Reson Imaging; 2013 Nov; 38(5):1129-39. PubMed ID: 23440909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resting-state Functional Magnetic Resonance Imaging Identifies Cerebrovascular Reactivity Impairment in Patients With Arterial Occlusive Diseases: A Pilot Study.
    Nishida S; Aso T; Takaya S; Takahashi Y; Kikuchi T; Funaki T; Yoshida K; Okada T; Kunieda T; Togashi K; Fukuyama H; Miyamoto S
    Neurosurgery; 2019 Nov; 85(5):680-688. PubMed ID: 30247676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrovascular Reactivity Measured with ASL Perfusion MRI, Ivy Sign, and Regional Tissue Vascularization in Moyamoya.
    Kronenburg A; Bulder MMM; Bokkers RPH; Hartkamp NS; Hendrikse J; Vonken EJ; Kappelle LJ; van der Zwan A; Klijn CJM; Braun KPJ
    World Neurosurg; 2019 May; 125():e639-e650. PubMed ID: 30716498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reliable quantification of BOLD fMRI cerebrovascular reactivity despite poor breath-hold performance.
    Bright MG; Murphy K
    Neuroimage; 2013 Dec; 83():559-68. PubMed ID: 23845426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BOLD cerebrovascular reactivity as a novel marker for crossed cerebellar diaschisis.
    Sebök M; van Niftrik CHB; Piccirelli M; Bozinov O; Wegener S; Esposito G; Pangalu A; Valavanis A; Buck A; Luft AR; Regli L; Fierstra J
    Neurology; 2018 Oct; 91(14):e1328-e1337. PubMed ID: 30185447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case study of magnetic resonance imaging of cerebrovascular reactivity: a powerful imaging marker for mild traumatic brain injury.
    Chan ST; Evans KC; Rosen BR; Song TY; Kwong KK
    Brain Inj; 2015; 29(3):403-7. PubMed ID: 25384127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invalidation of fMRI experiments secondary to neurovascular uncoupling in patients with cerebrovascular disease.
    Para AE; Sam K; Poublanc J; Fisher JA; Crawley AP; Mikulis DJ
    J Magn Reson Imaging; 2017 Nov; 46(5):1448-1455. PubMed ID: 28152241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous phase-contrast MRI and PET for noninvasive quantification of cerebral blood flow and reactivity in healthy subjects and patients with cerebrovascular disease.
    Ishii Y; Thamm T; Guo J; Khalighi MM; Wardak M; Holley D; Gandhi H; Park JH; Shen B; Steinberg GK; Chin FT; Zaharchuk G; Fan AP
    J Magn Reson Imaging; 2020 Jan; 51(1):183-194. PubMed ID: 31044459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic evaluation of patients with Moyamoya Angiopathy: comparison of resting-state fMRI to breath-hold fMRI and [
    Zerweck L; Roder C; Hauser TK; Thurow J; Mengel A; Tatagiba M; Khan N; Meyer PT; Ernemann U; Klose U
    Neuroradiology; 2022 Mar; 64(3):553-563. PubMed ID: 34570251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting Ischemic Risk Using Blood Oxygen Level-Dependent MRI in Children with Moyamoya.
    Dlamini N; Slim M; Kirkham F; Shroff M; Dirks P; Moharir M; MacGregor D; Robertson A; deVeber G; Logan W
    AJNR Am J Neuroradiol; 2020 Jan; 41(1):160-166. PubMed ID: 31806596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing cerebrovascular reactivity measured using BOLD and cerebral blood flow MRI: The effect of basal vascular tension on vasodilatory and vasoconstrictive reactivity.
    Halani S; Kwinta JB; Golestani AM; Khatamian YB; Chen JJ
    Neuroimage; 2015 Apr; 110():110-23. PubMed ID: 25655446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The voxel-wise analysis of false negative fMRI activation in regions of provoked impaired cerebrovascular reactivity.
    van Niftrik CHB; Piccirelli M; Muscas G; Sebök M; Fisher JA; Bozinov O; Stippich C; Valavanis A; Regli L; Fierstra J
    PLoS One; 2019; 14(5):e0215294. PubMed ID: 31059517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of baseline CO
    van Niftrik CHB; Piccirelli M; Bozinov O; Maldaner N; Strittmatter C; Pangalu A; Valavanis A; Regli L; Fierstra J
    Magn Reson Imaging; 2018 Jun; 49():123-130. PubMed ID: 29447850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
    Kuhn FP; Warnock G; Schweingruber T; Sommerauer M; Buck A; Khan N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):965-71. PubMed ID: 25813061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrovascular reactivity measured with arterial spin labeling and blood oxygen level dependent techniques.
    Zhou Y; Rodgers ZB; Kuo AH
    Magn Reson Imaging; 2015 Jun; 33(5):566-76. PubMed ID: 25708263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of BOLD cerebrovascular reactivity mapping and DSC MR perfusion imaging for prediction of neurovascular uncoupling potential in brain tumors.
    Pillai JJ; Zacà D
    Technol Cancer Res Treat; 2012 Aug; 11(4):361-74. PubMed ID: 22376130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged Mean Transit Time Detected by Dynamic Susceptibility Contrast Magnetic Resonance Imaging Predicts Cerebrovascular Reserve Impairment in Patients with Moyamoya Disease.
    Kawano T; Ohmori Y; Kaku Y; Muta D; Uekawa K; Nakagawa T; Amadatsu T; Kasamo D; Shiraishi S; Kitajima M; Kuratsu J
    Cerebrovasc Dis; 2016; 42(1-2):131-8. PubMed ID: 27088711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precision of cerebrovascular reactivity assessment with use of different quantification methods for hypercapnia functional MR imaging.
    Goode SD; Krishan S; Alexakis C; Mahajan R; Auer DP
    AJNR Am J Neuroradiol; 2009 May; 30(5):972-7. PubMed ID: 19435945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrovascular reactivity by quantitative magnetic resonance angiography with a Co₂ challenge. Validation as a new imaging biomarker.
    Caputi L; Ghielmetti F; Faragò G; Longaretti F; Lamperti M; Anzola GP; Carriero MR; Charbel FT; Bruzzone MG; Parati E; Ciceri E
    Eur J Radiol; 2014 Jun; 83(6):1005-1010. PubMed ID: 24721002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.